DispatchHealth is a technology company.
DispatchHealth has raised $734.0M across 5 funding rounds.
DispatchHealth has raised $734.0M in total across 5 funding rounds.
# DispatchHealth: A Healthcare Technology Platform, Not a Pure Tech Company
DispatchHealth is primarily a healthcare services company with significant technology components, rather than a technology company in the traditional sense. While the company has developed proprietary technology platforms to enable its operations, its core business model centers on delivering in-home medical care services directly to patients.
What DispatchHealth Builds: DispatchHealth operates a platform that deploys medical teams directly into patients' homes to provide urgent and acute care services.[3] The company offers same-day medical care for a range of conditions, from urgent health concerns to complex hospital-level treatments traditionally delivered in hospital settings, such as heart failure, pneumonia, and cancer.[3]
Who It Serves: DispatchHealth serves patients, health systems, payers (insurance companies), and primary care providers.[3] The company partners with nearly 40 health systems and operates across 50 major metropolitan areas.[3]
Problem It Solves: DispatchHealth addresses hospital capacity constraints and patient access to care by enabling high-acuity medical treatment in home settings. The combined entity (following its 2025 merger with Medically Home) is projected to free up more than 62,000 hospital bed days per year.[3] The service also reduces unnecessary emergency room visits and hospital readmissions while lowering healthcare costs.[4]
Growth Momentum: Founded in 2013, DispatchHealth has treated more than 1.2 million people across over 20 states and raised over $700 million in funding, including a $330 million raise in 2022.[2] The company achieved significant scale by joining Y Combinator's Winter 2021 cohort and expanded to operate in all 50 states before pivoting in 2023 to focus on licensing its technology to other hospital-at-home providers.[1] In June 2025, DispatchHealth completed its acquisition of Medically Home, creating a combined entity with over 2,200 employees.[4]
DispatchHealth was founded in 2013 by Dr. Mark Prather and Kevin Riddleberger, PA-C, MBA, both medical professionals with decades of direct patient care experience.[6] The founders were inspired by the conviction that there are multiple effective approaches to practicing high-quality medicine and created the company with a mission to bring compassionate, comfortable care within reach for more patients.[6]
The company's early growth accelerated through its Y Combinator participation in Winter 2021, which helped it scale from a couple million dollars in revenue to operating nationally.[1] A pivotal moment came in 2023 when DispatchHealth shifted its strategy from direct service delivery to building and licensing its technology platform to other hospital-at-home providers—a strategic pivot that positioned it as an enabler of the broader hospital-at-home movement.[1]
DispatchHealth is riding the hospital-at-home trend, which gained momentum during the COVID-19 pandemic as hospitals faced capacity constraints.[4] The U.S. Centers for Medicare & Medicaid Services (CMS) formalized this shift by creating the Acute Hospital Care At Home program in 2020, which allows approved Medicare-certified facilities to provide inpatient-level care in patients' homes.[4]
The timing is critical: as healthcare systems grapple with bed shortages, rising costs, and aging populations, the hospital-at-home model offers a scalable alternative. However, the regulatory environment remains uncertain—the CMS program operates on a temporary waiver, though recent government funding extensions have provided continuity through September 2025.[4]
DispatchHealth's 2025 merger with Medically Home signals industry consolidation around the hospital-at-home model, suggesting that scale, technology integration, and partnerships with major health systems are becoming prerequisites for success in this space. The combined entity's 20,000 annual admissions, while significant, still represents "a drop in the bucket" of overall acute hospital admissions, indicating substantial room for market expansion.[2]
DispatchHealth's evolution from a direct-care provider to a technology platform licensee reflects a maturing market recognizing that the hospital-at-home model requires both clinical excellence and sophisticated operational infrastructure. The company's ability to partner with major health systems and payers—rather than compete directly—positions it as foundational infrastructure for healthcare delivery transformation.
The key uncertainties ahead are regulatory: sustained CMS support for hospital-at-home programs and reimbursement models will determine whether this remains a niche service or becomes mainstream. If regulatory tailwinds continue, DispatchHealth's technology platform and clinical expertise could become the backbone for a significant portion of acute care delivery. If regulatory support wanes, the company faces pressure to demonstrate cost-effectiveness and clinical outcomes compelling enough to justify adoption without government subsidies.
DispatchHealth has raised $734.0M in total across 5 funding rounds.
DispatchHealth's investors include Echo Health Ventures, Oak HC/FT, Optum Ventures, Questa Capital, Tiger Global Management, Upfront Ventures, Vensana Capital, Kinnevik, Northzone, RRE Ventures, Sapphire Ventures, Work-Bench.
DispatchHealth has raised $734.0M across 5 funding rounds. Most recently, it raised $330.0M Series E in November 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2022 | $330.0M Series E | Echo Health Ventures, Oak HC/FT, Optum Ventures, Questa Capital, Tiger Global Management, Upfront Ventures, Vensana Capital | |
| Mar 1, 2021 | $200.0M Series D | Kinnevik, Northzone, Oak HC/FT, Questa Capital, RRE Ventures, Sapphire Ventures, Tiger Global Management, Upfront Ventures, Vensana Capital, Work-Bench | |
| Jun 1, 2020 | $140.0M Series C | Echo Health Ventures, Oak HC/FT, Optum Ventures, Questa Capital, Tiger Global Management, Upfront Ventures, Vensana Capital | |
| May 1, 2019 | $33.0M Series B | Echo Health Ventures, Oak HC/FT, Optum Ventures, Questa Capital, Tiger Global Management, Vensana Capital | |
| Sep 1, 2017 | $31.0M Venture Round | Questa Capital, Vensana Capital |